🇺🇸 Extended-Release Buprenorphine Injection in United States

Extended-Release Buprenorphine Injection (Extended-Release Buprenorphine Injection) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Extended-Release Buprenorphine Injection in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Extended-Release Buprenorphine Injection approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Extended-Release Buprenorphine Injection in United States?

NYU Langone Health is the originator. The local marketing authorisation holder may differ — check the official source linked above.